Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer

Journal of Histochemistry and Cytochemistry

Volumn 57, Issue 5, 2009, Pages 513-521

  Cho, HanByoul ^a   Kim, Jae Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Lipocalin2; NGAL; Ovarian cancer; Tumor marker

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; FLUORESCENT DYE; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; UPREGULATION; BIOSYNTHESIS; BLOOD; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; ROC CURVE; SERUM; SURVIVAL; TUMOR CELL LINE; TUMOR RECURRENCE;

ACUTE-PHASE PROTEINS; ADULT; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOCALINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; REFERENCE VALUES; ROC CURVE; SERUM; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 66149130751     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2009.953257     Document Type: Article

References (28)

1. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 108:389-397
2. Brower V (2005) Feeding the flame: new research adds to role of inflammation in cancer development. J Natl Cancer Inst 97:251-253
3. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, Lee K (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58:15-23
4. Cho H, Kang ES, Hong SW, Oh YJ, Choi SM, Kim SW, Kim SH, et al. (2008) Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. Mol Cell Biochem 319:189-201
5. Cooper CE, Porter JB (1997) Ribonucleotide reductase, lipoxygenase and the intracellular low-molecular-weight iron pool. Biochem Soc Trans 25:75-80
6. Devireddy LR, Teodoro JG, Richard FA, Green MR (2001) Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293:829-834
7. Fujita M, Enomoto T, Murata Y (2003) Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol 202:97-99
8. Furutani M, Arii S, Mizumoto M, Kato M, Imamura M (1998) Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 122:209-214
9. Gagne JP, Gagne P, Hunter JM, Bonicalzi ME, Lemay JF, Kelly I, Le Page C, et al. (2005) Proteome profiling of human epithelial ovarian cancer cell line TOV-112D. Mol Cell Biochem 275:25-55
10. Hraba-Renevey S, Turler H, Kress M, Salomon C, Weil R (1989) SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4:601-608
11. Jacobs IJ, Menon U (2004) Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics 3:355-366
12. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
13. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425-10432
14. Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, Quinn MA, et al. (2007) Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epitheliomesenchymal transition. Int J Cancer 120:2426-2434
15. Liu Q, Nilsen-Hamilton M (1995) Identification of a new acute phase protein. J Biol Chem 270:22565-22570
16. Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ (2007) Biomarker discovery in epithelial ovarian cancer by genomic approaches. Adv Cancer Res 96:1-22
17. Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, et al. (2008) Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 98:1540-1547
18. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38:414-420
19. Ordonez NG (2003) Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol 27:1418-1428
20. Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H (1997) Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 28: 734-739
21. Pieretti M, Hopenhayn-Rich C, Khattar NH, Cao Y, Huang B, Tucker TC (2002) Heterogeneity of ovarian cancer: relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival. Cancer Invest 20:11-23
22. Raetz EA, Moos PJ (2004) Impact of microarray technology in clinical oncology. Cancer Invest 22:312-320
23. Shibusa T, Shijubo N, Abe S (1998) Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res 4:1483-1487
24. Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, Gould MN (1998) Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79:565-572
25. Wong KK, Cheng RS, Mok SC (2001) Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques 30:670-675
26. Xu S, Venge P (2000) Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482:298-307
27. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, et al. (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10:1045-1056
28. Yin BW, Dnistrian A, Lloyd KO (2002) Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer 98: 737-740